Gerald Batist

20.2k total citations · 6 hit papers
329 papers, 13.2k citations indexed

About

Gerald Batist is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerald Batist has authored 329 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Oncology, 130 papers in Molecular Biology and 54 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerald Batist's work include Cancer Treatment and Pharmacology (45 papers), Glutathione Transferases and Polymorphisms (39 papers) and Colorectal Cancer Treatments and Studies (39 papers). Gerald Batist is often cited by papers focused on Cancer Treatment and Pharmacology (45 papers), Glutathione Transferases and Polymorphisms (39 papers) and Colorectal Cancer Treatments and Studies (39 papers). Gerald Batist collaborates with scholars based in Canada, United States and France. Gerald Batist's co-authors include Charles E. Myers, Kenneth H. Cowan, Birandra K. Sinha, Aspandiar G. Katki, Moulay A. Alaoui‐Jamali, Anil Tulpule, Weimin Miao, Mustapha Kandouz, P. James Scrivens and George D. Carystinos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Gerald Batist

312 papers receiving 12.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

2001 882 citations Gerald Batist et al. Journal of Clinical Oncology profile →
Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions

2016 877 citations Gerald Batist et al. profile →
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

1986 724 citations Gerald Batist et al. Journal of Biological Chemistry profile →
Use of Statins and the Risk of Death in Patients With Prostate Cancer

2013 512 citations Oriana Hoi Yun Yu, María Eberg et al. Journal of Clinical Oncology profile →
Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

2001 507 citations Gerald Batist et al. Journal of Clinical Oncology profile →
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion

1985 493 citations Gerald Batist et al. profile →

Peers

Countries citing papers authored by Gerald Batist

Since Specialization

Citations

This map shows the geographic impact of Gerald Batist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Batist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Batist more than expected).

Fields of papers citing papers by Gerald Batist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Batist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Batist. The network helps show where Gerald Batist may publish in the future.

Co-authorship network of co-authors of Gerald Batist

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Batist. A scholar is included among the top collaborators of Gerald Batist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Batist. Gerald Batist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis 2025 ·Current Oncology ·Matthew Dankner, (unknown), Mark Sorin, (unknown), (unknown), (unknown), Jamie Magrill, (unknown), Joan Miguel Romero, Gerald Batist, Petr Kavan, April A. N. Rose, (unknown)	0
2	Patient Preferences for Metastatic Colorectal Cancer Treatment: A Multi-method Approach Using Discrete Choice Experiments and Best–Worst Scaling 2025 ·Patient ·(unknown), Karen V. MacDonald, (unknown), Gerald Batist, Winson Y. Cheung, Sharlene Gill, Benjamin A. Goldenberg, Yoo‐Joung Ko, Deborah A. Marshall, (unknown)	0
3	New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices 2024 ·Current Oncology ·David J. Stewart, (unknown), Sandeep Sehdev, (unknown), Vishal Navani, Nigel S. B. Rawson, Di Jiang, (unknown), Paul Wheatley‐Price, Geoffrey Liu, Alan Kaplan, Silvana Spadafora, Shaun G. Goodman, Rebecca C. Auer, Gerald Batist	5
4	The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers 2024 ·Cancers ·(unknown), (unknown), Matthew Dankner, David W. Cescon, Anna Spreafico, (unknown), Petr Kavan, Gerald Batist, April A. N. Rose	7
5	mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA -Altered Tumors 2024 ·Cancer Research Communications ·Constance A. Sobsey, (unknown), (unknown), (unknown), Robert Popp, René P. Zahedi, Elza C. de Bruin, Christoph H. Borchers, Gerald Batist	2
6	A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy 2023 ·International Journal of Molecular Sciences ·Karen Gambaro, Maud Marques, (unknown), (unknown), Cyrla Hoffert, Archana Srivastava, (unknown), Thierry Alcindor, Adrian Langleben, Lucas Sidéris, Mahmoud Abdelsalam, Mustapha Tehfé, Félix Couture, Gerald Batist, Petr Kavan	0
7	Treatment Access, Health Economics, and the Wave of a Magic Wand 2022 ·Current Oncology ·David J. Stewart, (unknown), Gerald Batist	3
8	Site-Specific Variation in Radiomic Features of Head and Neck Squamous Cell Carcinoma and Its Impact on Machine Learning Models 2021 ·Cancers ·Xiaoyang Liu, Farhad Maleki, Nikesh Muthukrishnan, Katie Ovens, Shao Hui Huang, (unknown), Griselda Romero-Sánchez, Sahir Bhatnagar, Avishek Chatterjee, Marc Pusztaszeri, Alan Spatz, Gerald Batist, Seyedmehdi Payabvash, Stefan P. Haider, Amit Mahajan, Caroline Reinhold, Behzad Forghani, Brian O’Sullivan, Eugene Yu, Reza Forghani	5
9	Orally Administered Multiple Dose Saltikva (Salmonella-IL2) in Conjunction with Folfirinox in a Patient with Stage IV Pancreatic Cancer: A Case Report 2020 ·Gerald Batist, (unknown), (unknown), (unknown), Daniel A. Saltzman	3
10	Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes 2019 ·Molecular Cancer Therapeutics ·(unknown), Maud Marques, Lise Tremblay, Nicole Bouchard, Razvan Diaconescu, Normand Blais, Christian Couture, Vincent Pelsser, Hangjun Wang, (unknown), Luisa Izzi, Karen Gambaro, Cyrla Hoffert, Archana Srivastava, Alan Spatz, Caroline Rousseau, (unknown), Victor Cohen, Gerald Batist, Jason Agulnik	20
11	Cancer!? I Don't Have Time for That: Impact of a Psychosocial Intervention for Young Adults with Cancer 2018 ·Journal of Adolescent and Young Adult Oncology ·Sylvie Aubin, Zeev Rosberger, (unknown), (unknown), Samara Perez, Sonja Lehmann, Gerald Batist, Petr Kavan	9
12	Nrf2 Transcription Factor Can Directly Regulate mTOR 2016 ·Journal of Biological Chemistry ·(unknown), Tahar Aboulkassim, Khalid Hilmi, (unknown), Gerald Batist	77
13	Use of Statins and the Risk of Death in Patients With Prostate Cancer breakdown → 2013 ·Journal of Clinical Oncology ·Oriana Hoi Yun Yu, María Eberg, Serge Benayoun, Armen Aprikian, Gerald Batist, Samy Suissa, Laurent Azoulay	512
14	Gap junctions and connexins as therapeutic targets in cancer 2010 ·Expert Opinion on Therapeutic Targets ·Mustapha Kandouz, Gerald Batist	106
15	Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors 2009 ·Clinical Cancer Research ·Gerald Batist, Karen A. Gelmon, Kim N., Wilson H. Miller, Stephen Chia, Lawrence D. Mayer, Christine E. Swenson, Andrew S. Janoff, Arthur C. Louie	166
16	Medication Problems in Older, Newly Diagnosed Cancer Patients in Canada: How Common are They? 2009 ·Drugs & Aging ·Martine Puts, (unknown), Johanne Monette, Véronique Girre, Christina Wolfson, Gerald Batist, Howard Bergman	57
17	A phase I and pharmacokinetic (PK) study of vinorelbine liposomes injection in patients with advanced solid tumors, non-Hodgkin’s lymphoma, and Hodgkin’s disease 2007 ·Molecular Cancer Therapeutics ·Gerald Batist, (unknown), John Sarantopoulos, Kamalesh K. Sankhala, (unknown), Biao Lu, Gavin Choy, Steven R. Deitcher	1
18	Surrogate Endpoints in Colorectal Cancer 2005 ·Current Oncology ·Gerald Batist	1
19	Regulation of the gap junction connexin 43 gene by androgens in the prostate 2001 ·Journal of Molecular Endocrinology ·(unknown), Laurence I. Alpert, Dale W. Laird, Gerald Batist, (unknown), MA Alaoui-Jamali	22
20	Induction of gamma-glutamyl transpeptidase activity by all-trans retinoic acid in cultured rat liver epithelial cells 1988 ·Biochemical and Biophysical Research Communications ·Ming‐Sound Tsao, Gerald Batist	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact